Primary immune thrombocytopenia Clinical Trials in Tianjin, Tianjin Municipality
6 recruitingTianjin, Tianjin Municipality, China
Showing 1–6 of 6 trials
Recruiting
Phase 1
Study of PN20 in Adult Patients With Primary Immune Thrombocytopenia (ITP)
Primary Immune Thrombocytopenia (ITP)
Chongqing Peg-Bio Biopharm Co., Ltd.12 enrolled5 locationsNCT06880081
Recruiting
Phase 1Phase 2
A Phase Ib/II Clinical Trial of Multiple Doses of STSA-1301 Subcutaneous Injection in Healthy Subjects and Patients With Immune Thrombocytopenia (ITP)
Primary Immune Thrombocytopenia (ITP)
Jiangsu BioJeTay Biotechnology Co., Ltd.56 enrolled7 locationsNCT06929299
Recruiting
Phase 2
Romiplostim N01 Combined With Glucocorticoids as the First-line Treatment for Newly Diagnosed Adult Primary Immune Thrombocytopenia: A Multicenter, Interventional Trial
Primary Immune Thrombocytopenia (ITP)
Institute of Hematology & Blood Diseases Hospital, China129 enrolled1 locationNCT06992128
Recruiting
Phase 3
A Study of TQB3473 Tablets Compared to Placebo in the Treatment of Adult Primary Immune Thrombocytopenia
Primary immune thrombocytopenia
Chia Tai Tianqing Pharmaceutical Group Co., Ltd.199 enrolled53 locationsNCT06900920
Recruiting
Phase 2
A Study of Romiplostim N01 as the First-line Treatment for Newly Diagnosed Adult Patients With ITP
Primary immune thrombocytopenia
Institute of Hematology & Blood Diseases Hospital, China129 enrolled1 locationNCT06658834
Recruiting
Phase 3
Evaluate the Efficacy and Safety of Orelabrutinib in Adult Patients With Chronic Primary Immune Thrombocytopenia
Chronic Primary Immune Thrombocytopenia (ITP)
Beijing InnoCare Pharma Tech Co., Ltd.195 enrolled45 locationsNCT06004856